Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
3 Biotech Stocks Set for Breakthroughs in 2024
01:34pm, Tuesday, 02'nd Jan 2024
As we break into the new year, investors are on the hunt for the best biotech stocks to buy. Indeed, 2024 could witness groundbreaking advancements in technology and science.
2 Biotech Stocks You Can Buy and Hold for the Next Decade
08:45am, Tuesday, 02'nd Jan 2024
AbbVie's recent major patent cliff won't kill its returns throughout the next decade. Axsome Therapeutics is gaining in prominence thanks to an exciting late-stage pipeline.
AbbVie to Present at the 42nd Annual J.P. Morgan Healthcare Conference
08:00am, Tuesday, 02'nd Jan 2024
NORTH CHICAGO, Ill. , Jan. 2, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 42nd Annual J.P.
3 Top Dividend Growth Stocks to Buy in 2024
05:50am, Tuesday, 02'nd Jan 2024
AbbVie is a Dividend King that's poised to return to solid growth. Bank of America has a strong record of dividend increases.
The 3 Hottest Dividend Stocks to Watch in 2024
05:21pm, Monday, 01'st Jan 2024
You know what I hate about the typical article about hottest dividend stocks to watch? You're excited about adding passive income to your portfolio, only to read about company after company that pays
January's 54 Dividend Kings: Buy 8, Watch 5
11:14am, Sunday, 31'st Dec 2023
"There is only one-criterion to be included among the Dividend Kings: a publicly-traded company must increase its total fiscal-year dividend-payout for a minimum of 50 consecutive-years."--Dogs of the
Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio
09:15am, Sunday, 31'st Dec 2023
Vici Properties is a casino-focused REIT whose dividend outpaces inflation. Amazon is becoming a major player in artificial intelligence and cloud computing.
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
10:31am, Friday, 29'th Dec 2023
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
AbbVie (ABBV) Laps the Stock Market: Here's Why
06:47pm, Wednesday, 27'th Dec 2023
AbbVie (ABBV) closed at $154.88 in the latest trading session, marking a +0.17% move from the prior day.
AbbVie's Recent ImmunoGen Acquisition Looks Brilliant: Here's Why
08:30am, Tuesday, 26'th Dec 2023
AbbVie needs to diversify its drug portfolio because of the loss of exclusive rights to Humira. The recent acquisition of ImmunoGen fills several needs and comes at an excellent time.
Pharmaceutical stocks to watch in 2024
02:53am, Monday, 25'th Dec 2023
As the new year beckons, the pharmaceutical industry is poised for more developments, building on advances made in 2023. The industry harbors several companies leading the way in groundbreaking innova
AbbVie Vs. GSK: Dual Dominance In Pharma
04:18am, Saturday, 23'rd Dec 2023
AbbVie and GSK are both solid investment choices in the biopharmaceutical industry. AbbVie's financials and forward outlook show strong performance alongside solid partnerships, which hint at growth p
29 Undervalued Dividend Aristocrats: December 2023
09:00am, Friday, 22'nd Dec 2023
The S&P 500 Dividend Aristocrats Index contains 67 dividend growth stocks called the Dividend Aristocrats.
Better Growth Stock: AbbVie vs. Abbott Laboratories
10:23am, Thursday, 21'st Dec 2023
AbbVie is a top drugmaker that is putting its free cash flow to use lately with a couple of acquisitions. Abbott Labs has a broader, more diverse business that recently generated double-digit growth.
7 Blue-Chip Dividend Stocks to Buy Before Dec. 31
07:08pm, Tuesday, 19'th Dec 2023
It's always a good time for investors to consider investing in blue-chip dividend stocks. In a sense, this class of equities is amongst the most established and stable investments possible.
